StradVision

475040 · KOSDAQ · ₩475040 · 스트라드비젼

₩2,275▼ ₩125 (5.21%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me

What brokers say about StradVision

No public broker reports on this company yet.

Calculated by JONBUR from publicly available broker reports. Reports belong to their publishers. Not financial advice. Includes brokers that publish research publicly; some brokers' reports are client-only and not included.

AI summary of public information

An AI summary of the public information on this company: filed financial statements, filings, prices and news headlines. It doesn't use broker reports; their targets and estimates are shown above.

StradVision is still loss-making, with TTM operating losses far larger than its revenue, though it signed a supply contract in October.

StradVision, a Seoul-based maker of AI camera vision software for cars, reported trailing twelve-month revenue of about ₩21.5B against an operating loss of about ₩52.9B as of H1 2026. The company holds ₩85.9B in cash against ₩5.0B of borrowings, and its shares closed at ₩2,275 on 30 October 2026, down 22.9% over one month and 10.8% over three months.

What stands out

  • Revenue grew 56.9% in 2025 to about ₩18.1B, but the operating loss widened to about ₩58.6B, an operating margin of -323.6%.
  • TTM free cash flow was about -₩43.9B, so the cash balance is being drawn down by operations.
  • Filings include a major sales or supply contract on 12 October 2026 and another on 20 August 2026, though the data does not give contract values or counterparties.
  • Valuation shows P/B of 1.4 and P/S of 5.7, while P/E is not meaningful because earnings are negative; the data gives no dividend and no fair value estimate.
  • Foreign ownership is 0% and short balance is 0.6%; over the last 20 days foreign investors were net sellers of about ₩1.0B while retail investors were net buyers of about ₩0.8B.

What to watch

  • The next filed results after the H1 2026 half-year report, to see whether losses narrow relative to revenue.
  • Further supply contract filings and whether they disclose revenue or customer details, which the current data does not.
  • The stock option grant and the shareholder meeting outcomes, which could affect dilution; the data does not state the size of the grant.

Data as of Oct 30, 2026 · written 4h ago

This is not financial advice.

Also known as: StradVision / 스트라드비젼 / 475040 / KRX:475040

Source: KRX statistical information